Cassava Sciences, Inc. (SAVA): Jim Cramer Says Eli Lilly Has The Edge

By Yahoo! Finance | Oct 17, 2024 at 09:25 PM EST

The article examines Jim Cramer's insights on market volatility and the impact of earnings reports on stock movements. It analyzes Cassava Sciences, Inc. and its recent developments, including an SEC settlement. The company's focus on neurodegenerative disease treatments and positive forecasts are highlighted.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.